Qiujin Jia

732 total citations
16 papers, 556 citations indexed

About

Qiujin Jia is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Qiujin Jia has authored 16 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in Qiujin Jia's work include Gut microbiota and health (5 papers), Cardiac Fibrosis and Remodeling (4 papers) and MicroRNA in disease regulation (3 papers). Qiujin Jia is often cited by papers focused on Gut microbiota and health (5 papers), Cardiac Fibrosis and Remodeling (4 papers) and MicroRNA in disease regulation (3 papers). Qiujin Jia collaborates with scholars based in China and United States. Qiujin Jia's co-authors include Junping Zhang, Shichao Lv, Yanyang Li, Ao Zhang, Xiaonan Zhang, Yingxi Yang, Yingyu Xie, Hao Li, Lirong Wang and Zhongwen Qi and has published in prestigious journals such as Construction and Building Materials, Renewable Energy and BioMed Research International.

In The Last Decade

Qiujin Jia

15 papers receiving 552 citations

Peers

Qiujin Jia
Qiujin Jia
Citations per year, relative to Qiujin Jia Qiujin Jia (= 1×) peers Mengchao Jin

Countries citing papers authored by Qiujin Jia

Since Specialization
Citations

This map shows the geographic impact of Qiujin Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiujin Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiujin Jia more than expected).

Fields of papers citing papers by Qiujin Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiujin Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiujin Jia. The network helps show where Qiujin Jia may publish in the future.

Co-authorship network of co-authors of Qiujin Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Qiujin Jia. A scholar is included among the top collaborators of Qiujin Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiujin Jia. Qiujin Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Wang, Hao, Qiujin Jia, Guogang Yang, et al.. (2025). Nanoscale modelling of compressive stress on oxygen transfer characteristics in catalyst layer of proton exchange membrane fuel cells. Renewable Energy. 241. 122348–122348. 2 indexed citations
3.
Zhang, Xiaonan, et al.. (2025). Shenmai Injection Reduces Cardiomyocyte Apoptosis Induced by Doxorubicin through miR-30a/Bcl-2. Chinese Journal of Integrative Medicine. 31(3). 240–250. 1 indexed citations
4.
Wei, Xiaoxiao, et al.. (2024). Enhancement in durability and performance for cement-based materials through tailored water-based graphene nanofluid additives. Construction and Building Materials. 457. 139455–139455. 5 indexed citations
5.
Zhang, Wanqin, Yunjiao Wang, Ao Zhang, et al.. (2021). TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies. Journal of Cardiovascular Translational Research. 14(6). 1117–1124. 46 indexed citations
6.
Zhang, Xiaonan, Shichao Lv, Wanqin Zhang, et al.. (2021). Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1. Biomedicine & Pharmacotherapy. 139. 111582–111582. 30 indexed citations
7.
Jia, Qiujin, et al.. (2021). [Systematic review of gut microbiota changes in patients with chronic heart failure].. PubMed. 49(10). 1012–1019. 5 indexed citations
8.
Wang, Yuan, Wanqin Zhang, Qiujin Jia, et al.. (2020). Roles of Biomarkers in Myocardial Fibrosis. Aging and Disease. 11(5). 1157–1157. 46 indexed citations
9.
Wang, Yuan, Qiujin Jia, Xiaoling Wang, et al.. (2020). Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload. International Journal of Hypertension. 2020. 1–14. 14 indexed citations
10.
Zhou, Huan, Bin Wang, Yingxi Yang, et al.. (2019). Exosomes in ischemic heart disease: novel carriers for bioinformation. Biomedicine & Pharmacotherapy. 120. 109451–109451. 24 indexed citations
11.
Jia, Qiujin, Lirong Wang, Xiaonan Zhang, et al.. (2019). Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota. Pharmacological Research. 151. 104552–104552. 88 indexed citations
12.
Zhang, Xiaonan, Qiujin Jia, Ao Zhang, et al.. (2019). The microRNA in ventricular remodeling: the miR-30 family. Bioscience Reports. 39(8). 63 indexed citations
13.
Jia, Qiujin, et al.. (2019). Endocrine organs of cardiovascular diseases: Gut microbiota. Journal of Cellular and Molecular Medicine. 23(4). 2314–2323. 31 indexed citations
14.
Zhou, Huan, Yingxi Yang, Qiujin Jia, et al.. (2019). Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature. BioMed Research International. 2019. 1–11. 85 indexed citations
15.
Jia, Qiujin, Hao Li, Huan Zhou, et al.. (2019). Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure. Cardiovascular Therapeutics. 2019. 1–10. 72 indexed citations
16.
Wang, Lirong, et al.. (2019). Role of cardiac progenitor cell‐derived exosome‐mediated microRNA‐210 in cardiovascular disease. Journal of Cellular and Molecular Medicine. 23(11). 7124–7131. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026